A clinical trial shows the feasibility of a noninvasive imaging approach to diagnose a surgically amenable subtype of primary aldosteronism — a common and often poorly managed form of hypertension.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Reincke, M. et al. Lancet Diabetes Endocrinol. 9, 876–892 (2021).
Brown, J. M. et al. Ann. Intern. Med. 173, 10–20 (2020).
Funder, J. W. et al. J. Clin. Endocrinol. Metab. 101, 1889–1916 (2016).
Wu, X. et al. Nat. Med. https://doi.org/10.1038/s41591-022-02114-5 (2022).
Williams, T. A. et al. Hypertension 72, 641–649 (2018).
Kamemura, K. et al. J. Hum. Hypertens. 31, 195–199 (2017).
Puar, T. H. et al. J. Hypertens. 40, 1179–1188 (2022).
Williams, T. A. et al. Lancet Diabetes Endocrinol. 5, 689–699 (2017).
Monticone, S. et al. J. Am. Coll. Cardiol. 69, 1811–1820 (2017).
Heinrich, D. A. et al. Eur. J. Endocrinol. 178, 605–611 (2018).
Silins, I. et al. Eur. J. Nucl. Med. Mol. Imaging https://doi.org/10.1007/s00259-022-05957-9 (2022).
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Williams, T.A., Reincke, M. Non-invasive detection of a common, surgically correctable form of hypertension. Nat Med 29, 31–32 (2023). https://doi.org/10.1038/s41591-022-02083-9